A retrospective study to determine clinical outcomes of oritavancin when compared to standard-of-care for in patients with gram-positive blood stream infections
Latest Information Update: 01 Feb 2023
At a glance
- Drugs Oritavancin (Primary) ; Ampicillin/sulbactam; Cefazolin; Ceftaroline fosamil; Daptomycin; Nafcillin; Oxacillin; Vancomycin
- Indications Gram-positive infections
- Focus Therapeutic Use
- 01 Feb 2023 New trial record